Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,653,183
-$3,422,619 QoQ
Shares Held
210,070
-45.5% QoQ
Ownership
0.722%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,756,303,735 across 280 Biotechnology names. ENTA ranks #138 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in ENTA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,653,183 | 210,070 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $6,075,802 | 385,276 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $3,296,405 | 275,389 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $6,482,034 | 857,412 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $4,696,912 | 850,890 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $5,347,999 | 930,087 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $8,815,220 | 850,890 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $12,040,868 | 928,363 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $16,605,542 | 951,062 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $835,627 | 74,810 | Shares | Other | 2023-11-14 | |
| 2022-06-30 | $2,371,063 | 50,160 | Shares | Other | 2022-08-15 | |
| 2021-12-31 | $723,122 | 9,670 | Shares | Other | 2022-02-14 | |
| 2020-12-31 | $418,979 | 9,952 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,599,278 | 34,934 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,618,883 | 131,824 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $12,958,354 | 251,961 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||